Songjiang Liu

Prof. Songjiang Liu


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 November 2025 in Discover Oncology
Verified
Journal Article
Open access
XYXinyu Yin
Xinyu Yin
YYYing Yang
Ying Yang
SLSongjiang Liu
Songjiang Liu
Extracellular adenosine has recently been identified as an immunological checkpoint mediator that hinders the immune response to malignancies. The production of adenosine is facilitated by the enzymatic activity of CD39 and CD73. There is an increasing body of evidence suggesting that CD39 and CD73, which are considered to be emerging immunological checkpoints, can transform adenosine triphosphate (ATP)-mediated pro-inflammatory tumor microenvironment (TME) into an adenosine-mediated immunosuppressive through purinergic pathway. The aim of this study was to review macrophages-based cancer immunotherapy by adenosinergic CD39 and CD73 as emerging immune checkpoints. We searched the PubMed, EMBASE, Web of Science, and Medline (Ovid) databases to find relevant studies between December 30, 2010, and December 30, 2024. The search strategy encompassed utilization of Cancer, Immune checkpoints, CD39, CD73, Immunotherapy as keywords. The case reports, reviews, evaluations, originals, and earlier meta-analyses were all included in the study. The inclusion criteria were the researches that investigated the functions of the adenosinergic immunological checkpoints CD39 and CD73 in cancer immunotherapy. Clinical studies have examined small molecule inhibitors or monoclonal antibodies that target the CD39/CD73 pathway in recent years. Cancer immunotherapy might profit from therapeutic inhibition of CD39 and CD73’s enzymatic activity, given that these two proteins are crucial for the conversion of ATP into adenosine. Multiple types of monoclonal antibodies have been developed and shown to inhibit CD39 or CD73. One benefit of using monoclonal antibodies to block CD39 and CD73 is that antibody medications usually have lengthy serum half-lives. Inhibiting CD39 and CD73 may contribute to limiting the progression of tumors and boost anti-tumor responses. Currently, one of the most promising strategies in immuno-oncology is to target CD39 and CD73 due to their extensive immune regulatory effects on tumor immunity.

8 November 2021 in Computational and Mathematical Methods in Medicine
Verified
Journal Article
Open access
PDF file
XSXizhe Sun
Xizhe Sun
LZLijia Zhang
Lijia Zhang
SLSongjiang Liu
Songjiang Liu
Background. Being potential field of research for tumor immunological therapy, the head and neck squamous cell carcinoma (HNSCC) is one of most discussed types of tumor. Recently, some clinical trials have also used immunological therapy and demonstrated a subset of HNSCC patients who have shown a clear longer survival time. Objective. To conduct further studies and deeper research in the immunological oncology of HNSCC, a more detailed description and comprehending of the complicated landscape of immune infiltrative may be required. Methods. Firstly, we have described the fraction of different infiltrating immune cells in the HNSCC tumor and then compared it to the normal tissue, and secondly, we have explored the clinical implications of various infiltrated immune cell fractions meticulously. The gene expression profiles of HNSCC tissue were obtained from databases of TCGA and GEO and utilized the deconvolution algorithm (CIBERSORT) to presume the fractions of 22 several immune sensitive cells. Results. Our results indicated that the immune infiltrating cell fractions were considerably different between HNSCC tumor tissue and paired normal tissue, but at the same time, we found a potential internal correlation among the immune cells and also showed the association between immune infiltrating cells and their clinical characteristics. It is worth noting that the resting dendritic cells and M1 macrophages were linked with a favorable prognosis, while the CD4+ T cells with a poorer outcome. Conclusion. Fractions of immune cell percentage were also associated with tumors pathological grade, age, and TNM stage.

28 May 2019 in BMJ Open
Verified
Journal Article
Open access
PDF file
YLYan Li
Yan Li
LHLihui Hou
Lihui Hou
YWYingji Wang
Yingji Wang
LXLiangzhen Xie
Liangzhen Xie
MZMeiwei Zhang
Meiwei Zhang
SLSongjiang Liu
Songjiang Liu
Introduction Approximately 5%–20% of reproductive women suffer from polycystic ovary syndrome (PCOS). Auricular points acupressure (AA) may serve as alternative management for PCOS for its benefits in both physical and psychological well-being. However, the effects of AA for insulin resistance (IR) in overweight/obese PCOS women have not been confirmed. Methods and analysis The present study is designed as a randomised, placebo-controlled pilot trial to evaluate the effectiveness and safety of AA in treating IR in women with PCOS. A total of 60 eligible PCOS subjects will be randomised into an intervention group (AA group) and a control group (sham AA group) in a ratio of 1:1. Magnetic beads will be taped to the auricular points by the same senior acupuncture specialist from the First Affiliated Hospital, Heilongjiang University of Chinese Medicine. The treatment will last for 12 weeks. Primary outcome measure will be changes in homeostasis model assessment of IR between baseline and after 3 months of AA/sham AA treatment. Secondary outcomes include hormonal profile, weight, waist/hip circumference, body mass index, blood pressure, Ferriman-Gallwey score, acne and the assessment of health-related quality of life. Outcome measures are collected at baseline and the end of treatment visit. Ethics and dissemination The protocol has been approved by the ethics committee of the First Affiliated Hospital of Heilongjiang University of Chinese Medicine (HZYLLKY201800301). Written informed consent will be obtained from all participants. The results will be disseminated through peer-reviewed journals for publications. Trial registration number NCT03546595; Pre-results.

24 September 2021 in Evidence-Based Complementary and Alternative Medicine
Verified
Journal Article
Open access
PDF file
YLYan Li
Yan Li
LZLijia Zhang
Lijia Zhang
JGJinjin Gao
Jinjin Gao
JYJun Yan
Jun Yan
XFXue Feng
Xue Feng
SLSongjiang Liu
Songjiang Liu
Background. Polycystic ovary syndrome (PCOS) is one of the most common endocrine disorders among women of reproductive age. As a widely used complementary and alternative therapy, acupuncture is increasingly used to treat PCOS. However, the effect of acupuncture in treating PCOS is uncertain, and the mechanisms are unclear. This systematic review aims to determine the efficacy of acupuncture on PCOS in animal preclinical models. Methods. Experimental animal studies of acupuncture in PCOS animal models were searched in PubMed, Web of Science, China National Knowledge Infrastructure, and the Chinese Science and Technology Periodical Database from inception to December 2020. The risk of bias was assessed using the Systematic Review Centre for Laboratory Animal Experimentation (SYRCLE) risk of bias tool. Results. A total of 358 studies were screened based on the title and abstract, and 31 studies were included. A total of 722 animals were involved, and all studies used either Wistar rats or SD rats. Twenty-six studies used electroacupuncture, 9 studies used manual acupuncture, and 5 of them employed both electroacupuncture and manual acupuncture. A total of 22 acupoints were involved; 7 studies followed the modern acupuncture pattern, and the rest followed classic acupuncture theory. Conclusions. The present review summarizes the current evidence of the effects of acupuncture on PCOS in animal models. Unfortunately, we could not draw a definite conclusion due to the methodological weakness of the included studies and the high heterogeneity. Well-designed studies are needed in the future to fill this gap.

15 May 2020 in Medicine
Verified
Journal Article
Open access
RMRui Ma
Rui Ma
YLYan Li
Yan Li
SLSongjiang Liu
Songjiang Liu
WZWenhui Zhao
Wenhui Zhao
Background: Hiccups are involuntary contractions of the diaphragm and intercostal muscles, which lead to sudden contractions of the glottis. CAM, such as acupuncture is commonly used and stimulation of the vagus nerve and interference with phrenic nerve conduction are also used to treat hiccups. However, there is little evidence on the effectiveness of acupuncture for cancer-related hiccups. We will plan to conduct a systematic review and meta-analysis of RCTs to evaluate the current evidence on the effects of acupuncture for cancer-related hiccups. Method: The following databases will be searched: PubMed, the Cochrane Library, Wanfang Data, China National Knowledge Infrastructure (CNKI), SinoMed, VIP, Medline, Embase, and EI. Randomized controlled trials will be included to evaluate the effect and safety of acupuncture on cancer patients with hiccups. We will set standards for the curative effect on the basis of the standard of cure and improvement for clinical disease diagnoses. The risk of bias will be assessed by the Cochrane risk of bias tool. We will conduct a meta-analysis and sensitivity analysis, as well as a subgroup analysis if high heterogeneity is present, using Revman 5.3. We will use funnel plots to identify potential reporting biases. We will test asymmetry using Egger test. The Grading of Recommendations Assessment, Development, and Evaluation (GRADE) will be used to evaluate the quality of evidence. Results: This study will be to assess the effect and safety of acupuncture for cancer-related hiccups. Conclusions: This study will assess the effect of acupuncture for cancer-related hiccups and provide reliable evidence for the choice of treatments.

3 April 2024 in Journal of Applied Genetics
Verified
Journal Article
Closed access
PDF file
XLXue Lei
Xue Lei
LZLijia Zhang
Lijia Zhang
YLYe Liu
Ye Liu
HSHeng Sun
Heng Sun
JYJun Yan
Jun Yan
SLSongjiang Liu
Songjiang Liu